Objective: To investigate the effect of sitting Baduanjin combined with exercise rehabilitation therapy on exercise tolerance, serum myocardial injury markers and quality of life of patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods: According to the method of random number table, the patients with ACS undergoing PCI in our hospital from April 2020 to May 2021 (n=120) were divided into the control group (exercise rehabilitation therapy, n=60) and the research group (sitting Baduanjin combined exercise rehabilitation therapy, n=60).. The patients in the control group received exercise rehabilitation therapy, and the patients in the study group received sitting Baduanjin combined exercise rehabilitation therapy. The cardiac function indexes [left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), N-terminal precursor of B-type brain natriuretic peptide (NT-proBNP), left ventricular end diastolic volume (LVEDV)], myocardial injury markers [creatine kinase isoenzyme (CK-MB), cardiac troponin I (cTnI)] exercise tolerance indexes [anaerobic threshold (AT), maximum oxygen uptake (VO2max), exercise duration (ED)] and quality of life [Seattle?Angina?Questionnaire (SAQ) score: physical activity limitation (PL), angina stability (AS), disease cognition (DS), angina attack (AF) and treatment satisfaction (TS)] in the two groups were compared, and the occurrence of adverse cardiovascular events in the two groups were recorded. Results: The incidence of adverse cardiovascular events in the study group was lower than that in the control group (P<0.05). LVEF in the study group was higher than that in the control group after 3 months of treatment, and LVEDD, LVEDV, NT-proBNP were lower than those in the control group (P<0.05). CK-MB and cTnI in the study group were lower than those in the control group after 3 months of treatment (P<0.05). AT, VO2max and ED in the study group were higher than those in the control group after 3 months of treatment (P<0.05). The scores of PL, AS, DS, AF, TS in the study group were higher than those in the control group after 3 months of treatment (P<0.05). Conclusion: Sitting Baduanjin combined with exercise rehabilitation therapy can promote the improvement of cardiac function in patients with ACS after PCI, reduce myocardial injury, and improve exercise endurance and quality of life. |